Calyxt Inc. (CLXT)
NASDAQ: CLXT
· Real-Time Price · USD
6.30
0.33 (5.53%)
At close: May 31, 2023, 10:00 PM
Company Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States.
The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content.
It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally.
The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015.
Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.
Calyxt, Inc. is a subsidiary of Cellectis S.A.
Calyxt Inc.
| Country | United States |
| IPO Date | Jul 20, 2017 |
| Industry | Packaged Foods |
| Sector | Consumer Defensive |
| Employees | 48 |
| CEO | Michael Allen Carr |
Contact Details
Address: 2800 Mount Ridge Road Roseville, Minnesota United States | |
| Website | https://calyxt.com |
Stock Details
| Ticker Symbol | CLXT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001705843 |
| CUSIP Number | 13173L107 |
| ISIN Number | US13173L1070 |
| Employer ID | 27-1967997 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Michael Allen Carr | Pres, Chief Executive Officer & Director |
| Dr. Travis J. Frey Ph.D. | Chief Technology Officer |
| William F. Koschak | Chief Financial Officer |
| Debra H. Frimerman | Gen. Counsel & Corporation Sec. |
| Dr. Daniel F. Voytas Ph.D. | Founder, Chief Science Officer & Chair of Scientific Advisory Board |
| Dr. Stephen M. Bravo | Chief Medical Officer |
| Gerry Nuovo | Senior Vice President of Bus. Devel. |
| Suellen Boot | Bus. Devel. Director |
| Trina Lundblad | Director of Communications |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 11, 2025 | 4 | Filing |
| Jun 10, 2025 | 4 | Filing |
| Jun 10, 2025 | SCHEDULE 13D/A | [Amend] Filing |
| Jun 06, 2025 | 8-K | Current Report |
| Jun 06, 2025 | 424B5 | Filing |
| Jun 04, 2025 | 8-K | Current Report |
| Jun 04, 2025 | 424B5 | Filing |
| May 27, 2025 | 8-K | Current Report |
| May 27, 2025 | 4 | Filing |
| May 27, 2025 | 4 | Filing |